0,893  0,004  TNF expression inhibitor
0,889  0,005  Antiinflammatory
0,854  0,010  Apoptosis agonist
0,841  0,010  Transcription factor NF kappa B inhibitor
0,785  0,013  Caspase 9 stimulant
0,769  0,011  Antineoplastic (lung cancer)
0,760  0,008  Antihypercholesterolemic
0,755  0,007  Chemopreventive
0,710  0,005  Antiparasitic
0,706  0,005  Nitric oxide antagonist
0,702  0,004  Antihelmintic
0,702  0,011  Carcinogenic
0,685  0,007  Antineoplastic (cervical cancer)
0,674  0,005  Antineoplastic enhancer
0,678  0,023  Antineoplastic (breast cancer)
0,645  0,013  Chemoprotective
0,645  0,024  CYP3A4 substrate
0,623  0,007  CYP2C19 inhibitor
0,623  0,013  Sensitization
0,607  0,005  Renal disease treatment
0,604  0,011  Hepatic disorders treatment
0,593  0,002  Abortion inducer
0,589  0,009  Antifungal
0,587  0,012  AR expression inhibitor
0,587  0,012  Cardioprotectant
0,575  0,017  Bone diseases treatment
0,558  0,006  Hair growth stimulant
0,532  0,006  Antiulcerative
0,530  0,005  Contraceptive
0,534  0,016  Antiosteoporotic
0,524  0,011  UDP-glucuronosyltransferase substrate
0,538  0,031  Antibacterial
0,519  0,018  Antipsoriatic
0,525  0,026  Antipruritic, allergic
0,508  0,019  NOS3 expression inhibitor
0,489  0,007  Interferon gamma antagonist
0,493  0,013  CYP3A4 inhibitor
0,496  0,021  Lipoprotein disorders treatment
0,520  0,045  Antidiabetic
0,520  0,045  Cyclophilin D inhibitor
0,506  0,031  Prostate cancer treatment
0,499  0,029  Respiratory analeptic
0,480  0,013  Skin irritative effect
0,506  0,039  Antileukemic
0,494  0,033  Teratogen
0,480  0,019  Antiprotozoal (Leishmania)
0,475  0,016  Antineoplastic (lymphoma)
0,456  0,003  Contraceptive female
0,459  0,007  UGT2B7 substrate
0,468  0,016  UGT2B4 substrate
0,482  0,033  Embryotoxic
0,471  0,022  Cardiovascular analeptic
0,471  0,026  Analeptic
0,475  0,041  CYP2C9 substrate
0,443  0,016  Antineoplastic (endocrine cancer)
0,441  0,015  Sedative
0,433  0,008  Antiacne
0,443  0,023  Proliferative diseases treatment
0,417  0,010  Prostate disorders treatment
0,413  0,011  Prostatic (benign) hyperplasia treatment
0,407  0,008  Lipocortins synthesis antagonist
0,408  0,015  Sodium/bile acid cotransporter inhibitor
0,405  0,013  Hepatoprotectant
0,392  0,005  Androgen antagonist
0,416  0,034  Cytotoxic
0,421  0,045  Cholesterol antagonist
0,380  0,005  Cholesterol synthesis inhibitor
0,377  0,005  Contraceptive male
0,419  0,057  Atherosclerosis treatment
0,405  0,043  Antineoplastic (ovarian cancer)
0,375  0,013  Antipruritic, non-allergic
0,399  0,041  CYP2C19 substrate
0,364  0,008  Acute respiratory distress syndrome (ARDS) treatment
0,373  0,037  Calcium channel activator
0,343  0,010  Neurotrophic factor enhancer
0,359  0,031  Antineoplastic (liver cancer)
0,393  0,066  Immunosuppressant
0,343  0,024  UGT1A1 substrate
0,375  0,059  Antineoplastic (colorectal cancer)
0,346  0,037  Mutagenic
0,342  0,037  Hypolipemic
0,362  0,058  Antineoplastic (colon cancer)
0,315  0,017  Lipid peroxidase inhibitor
0,347  0,053  Antineoplastic (pancreatic cancer)
0,313  0,020  Antieczematic atopic
0,309  0,020  Anesthetic
0,336  0,050  Antioxidant
0,314  0,030  Anesthetic general
0,331  0,049  Antineoplastic (multiple myeloma)
0,312  0,030  Growth hormone agonist
0,351  0,071  Inflammatory Bowel disease treatment
0,286  0,012  UGT2B9 substrate
0,278  0,008  Antieczematic
0,280  0,011  Endometrios treatment
0,318  0,051  NOS2 expression inhibitor
0,271  0,014  Antifungal enhancer
0,285  0,033  UGT1A4 substrate
0,263  0,015  Psychosexual dysfunction treatment
0,277  0,034  P-glycoprotein inhibitor
0,252  0,009  Choleretic
0,314  0,072  Caspase 3 stimulant
0,318  0,078  ICAM1 expression inhibitor
0,305  0,069  Antiepileptic
0,310  0,077  Immunomodulator
0,233  0,010  Arachidonic acid antagonist
0,306  0,094  Vasodilator, peripheral
0,238  0,028  Antiviral (Influenza A)
0,237  0,030  UGT2B15 substrate
0,220  0,016  Microtubule formation inhibitor
0,265  0,063  Gastrin inhibitor
0,223  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,217  0,017  Farnesoid X receptor antagonist
0,232  0,032  Melanin inhibitor
0,203  0,004  Anabolic
0,209  0,010  Adenylate cyclase stimulant
0,246  0,048  Antiviral (Influenza)
0,202  0,005  Androgen agonist
0,284  0,090  CYP2D6 substrate
0,212  0,021  Autism spectrum disorders treatment
0,325  0,135  Antiarthritic
0,226  0,038  UGT1A3 substrate
0,196  0,011  TRPA1 agonist
0,272  0,090  CTGF expression inhibitor
0,184  0,006  UGT2B11 substrate
0,207  0,032  UGT2B10 substrate
0,215  0,041  Protein-tyrosine phosphatase inhibitor
0,289  0,116  GST A substrate
0,194  0,022  Antineoplastic antibiotic
0,244  0,075  Platelet antagonist
0,163  0,005  Hypercalcemia treatment
0,177  0,020  Antineoplastic alkaloid
0,204  0,050  Eye irritation, high
0,250  0,099  Antihypoxic
0,173  0,023  Alcohol dehydrogenase substrate
0,240  0,095  Spasmolytic
0,201  0,059  Antiviral (Hepatitis)
0,155  0,015  Transcription factor NF kappa B stimulant
0,143  0,006  Progesterone antagonist
0,165  0,029  Menstruation disorders treatment
0,216  0,080  Peptidyltransferase inhibitor
0,146  0,013  CDC25A inhibitor
0,243  0,110  Metabolic disease treatment
0,157  0,025  Sulfotransferase substrate
0,182  0,054  Antiviral (Hepatitis C)
0,231  0,104  Immunostimulant
0,136  0,009  Na+ K+ transporting ATPase inhibitor
0,129  0,004  Postcoital contraceptive
0,217  0,096  Antidiabetic symptomatic
0,163  0,042  DNA polymerase I inhibitor
0,127  0,008  5-Alpha-reductase inhibitor
0,245  0,126  Antihypertensive
0,160  0,042  Antihyperlipoproteinemic
0,247  0,131  Apoptosis antagonist
0,175  0,059  Interleukin 6 antagonist
0,131  0,016  Antiprotozoal activity enhancer
0,137  0,023  Antiviral (Coronavirus)
0,137  0,023  Antiviral (SARS coronavirus)
0,143  0,030  Antiinfertility, female
0,126  0,014  Postmenopausal disorders treatment
0,113  0,005  Heme oxygenase stimulant
0,120  0,018  Glycine receptor antagonist
0,146  0,044  Growth stimulant
0,144  0,045  Vanilloid 1 agonist
0,125  0,027  ABCA1 expression enhancer
0,124  0,027  SULT1E1 substrate
0,213  0,115  Huntington's disease treatment
0,194  0,098  Angiogenesis stimulant
0,175  0,079  LDLR expression enhancer
0,168  0,074  Sigma receptor agonist
0,122  0,031  Antispirochetal
0,141  0,051  Adenylate cyclase inhibitor
0,208  0,119  Antineoplastic (melanoma)
0,094  0,007  RNA-directed RNA polymerase stimulant
0,166  0,080  Toxic, respiratory center
0,094  0,009  Aldosterone antagonist
0,190  0,110  Cytostatic
0,206  0,128  Antidiabetic (type 2)
0,147  0,070  Protein kinase stimulant
0,081  0,006  Glucocorticoid antagonist
0,106  0,032  Inducible nitric-oxide synthase inhibitor
0,166  0,092  Antirickettsial
0,084  0,011  Lipocortins synthesis agonist
0,137  0,064  Cocaine dependence treatment
0,119  0,048  UGT2B1 substrate
0,076  0,005  Parathyroid hormone antagonist
0,174  0,104  Antihypertriglyceridemic
0,093  0,025  Glycine receptor agonist
0,127  0,060  Proteasome inhibitor
0,091  0,023  Anticholelithogenic
0,070  0,004  ATP citrate lysase inhibitor
0,106  0,041  Actinic keratosis treatment
0,213  0,152  Antineoplastic (brain cancer)
0,148  0,089  Uterine stimulant
0,117  0,061  Estrogen antagonist
0,101  0,047  Paget's disease treatment
0,089  0,035  Narcotic antagonist
0,077  0,025  Antimycoplasmal
0,165  0,113  Insulin sensitizer
0,056  0,004  Vitamin D receptor antagonist
0,060  0,009  Hypogonadism treatment
0,075  0,027  Andropause treatment
0,056  0,009  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,054  0,007  Prostaglandin D2 agonist
0,064  0,017  Mineralocorticoid receptor antagonist
0,150  0,106  Phospholipase C inhibitor
0,046  0,003  Vitamin D receptor agonist
0,075  0,034  SULT2A1 substrate
0,097  0,056  Bile acid receptor antagonist
0,059  0,019  Adenylate cyclase 1 inhibitor
0,211  0,171  GST M1-1 substrate
0,131  0,092  Genotoxic
0,051  0,015  GABA uptake inhibitor
0,124  0,089  Neurotrophic factor
0,062  0,028  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,123  0,090  Antimutagenic
0,061  0,030  Estrogen agonist
0,149  0,118  Cardiodepressant
0,045  0,016  Cholesterol absorption inhibitor
0,108  0,079  Carcinogenic, group 3
0,154  0,128  Antineoplastic (glioma)
0,040  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,043  0,018  Glucose-6-phosphate dehydrogenase inhibitor
0,054  0,030  Anesthetic inhalation
0,075  0,051  Antibiotic
0,182  0,158  UGT1A9 substrate
0,155  0,132  Antiparkinsonian, rigidity relieving
0,051  0,028  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,050  0,028  Microtubule stabilization
0,116  0,093  Skin whitener
0,128  0,106  Antifungal (Cryptococcus)
0,032  0,010  Retinoid X gamma receptor antagonist
0,028  0,006  Glucocorticoid agonist
0,140  0,118  Platelet adhesion inhibitor
0,065  0,044  Hyperparathyroidism treatment
0,220  0,199  Rheumatoid arthritis treatment
0,083  0,064  Ornithine decarboxylase inhibitor
0,030  0,010  Retinoid X gamma receptor agonist
0,154  0,135  Antiglaucomic
0,027  0,008  Progesterone agonist
0,030  0,012  Hedgehog signaling activator
0,161  0,143  Antipyretic
0,054  0,036  Protein 50S ribosomal subunit inhibitor
0,026  0,009  Corticosteroid-like
0,024  0,008  Progesterone receptor B antagonist
0,027  0,012  Estrone sulfatase inhibitor
0,213  0,199  15-Lipoxygenase inhibitor
0,057  0,043  Aromatase inhibitor
0,047  0,033  Potassium channel Kv1.3 blocker
0,130  0,119  Ca2+-transporting ATPase inhibitor
0,073  0,062  Antitreponemal
0,168  0,158  Antihypotensive
0,023  0,013  Retinoid X beta receptor agonist
0,125  0,115  Pregnane X receptor agonist
0,080  0,070  3C-Like protease (SARS coronavirus) inhibitor
0,034  0,025  HMG CoA reductase inhibitor
0,087  0,080  Glutathione S-transferase substrate
0,029  0,024  Prostaglandin agonist
0,037  0,032  Membrane dipeptidase inhibitor
0,164  0,160  5 Hydroxytryptamine release stimulant
0,012  0,008  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,062  0,058  Premenstrual syndrome treatment
0,021  0,018  Retinoic acid gamma receptor agonist
0,158  0,155  VCAM1 expression inhibitor
0,004  0,003  Vitamin D-like
0,029  0,027  Estrogen receptor alpha agonist
0,095  0,094  Electron transport complex I inhibitor
0,135  0,135  Antineoplastic (glioblastoma multiforme)
0,069  0,069  Estrogen receptor alpha antagonist
0,044  0,044  HCV NS3/NS4A protease inhibitor
0,198  0,198  Stroke treatment

